Photo-products of retinal pigment epithelial bisretinoids react with cellular thiols

Molecular Vision

Volumn 17, Issue , 2011, Pages 1839-1849

  Yoon, Kee Dong ^a   Yamamoto, Kazunori ^a   Zhou, Jilin ^a   Sparrow, Janet R ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

A2E; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; METHYLGLYOXAL; RETINOID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHEMICAL REACTION KINETICS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; PHOTODEGRADATION; PHOTOOXIDATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REDUCTION;

ALDEHYDES; CELL LINE; CELL-FREE SYSTEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORIMETRY; EPITHELIAL CELLS; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE TRANSFERASE; HUMANS; LIGHT; LIPOFUSCIN; MACULAR DEGENERATION; OXIDATION-REDUCTION; PHOTOCHEMICAL PROCESSES; RETINAL PIGMENT EPITHELIUM; RETINAL PIGMENTS; RETINOIDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFHYDRYL COMPOUNDS;

EID: 79960728809     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009; 390:191-214.
2. Ballatori N, Krance SM, Marchan R, Hammond CL. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 2009; 30:13-28.
3. Sparrow JR, Wu Y, Kim CY, Zhou J. Phospholipid meets alltrans- retinal: the making of RPE bisretinoids. J Lipid Res 2010; 51:247-61.
4. Sakai N, Decatur J, Nakanishi K, Eldred GE. Ocular age pigment "A2E": An unprecedented pyridinium bisretinoid. J Am Chem Soc 1996; 118:1559-60.
5. Eldred GE, Lasky MR. Retinal age pigments generated by selfassembling lysosomotropic detergents. Nature 1993; 361:724-6.
6. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow JR. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci USA 1998; 95:14609-13.
7. Ben-Shabat S, Parish CA, Vollmer HR, Itagaki Y, Fishkin N, Nakanishi K, Sparrow JR. Biosynthetic studies of A2E, a major fluorophore of RPE lipofuscin. J Biol Chem 2002; 277:7183-90.
8. Wu Y, Fishkin NE, Pande A, Pande J, Sparrow JR. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J Biol Chem 2009; 284:20155-66.
9. Kim SR, Jang YP, Jockusch S, Fishkin NE, Turro NJ, Sparrow JR. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci USA 2007; 104:19273-8.
10. Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, Nakanishi K. Formation of a nona-oxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew Chem Int Ed 2002; 41:814-7.
11. Sparrow JR, Zhou J, Ben-Shabat S, Vollmer H, Itagaki Y, Nakanishi K. Involvement of oxidative mechanisms in blue light induced damage to A2E-laden RPE. Invest Ophthalmol Vis Sci 2002; 43:1222-7.
12. Wu Y, Yanase E, Feng X, Siegel MM, Sparrow JR. Structural characterization of bisretinoid A2E photocleavage products and implications for age-related macular degeneration. Proc Natl Acad Sci USA 2010; 107:7275-80.
13. Thornalley PJ. Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems - role in ageing and disease. Drug Metabol Drug Interact 2008; 23:125-50.
14. Crabb JW, Miyagi M, Gu X, Shadrach K, West KA, Sakaguchi H, Kamei M, Hasan A, Yan L, Raybourn ME, Salomon RG, Hollyfield JG. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99:14682-7.
15. Handa JT, Verzijl N, Matsunaga H, Aotaki-Keen A, Lutty GA, Koppele JM, Miyata T, Hjelmeland LM. Increase in advanced glycation end product pentosidine in Bruch's membrane with age. Invest Ophthalmol Vis Sci 1999; 40:775-9.
16. Curcio CA, Millican CL, Bailey T, Kruth HS. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci 2001; 42:265-74.
17. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 2002; 134:411-31.
18. Sparrow JR, Parish CA, Hashimoto M, Nakanishi K. A2E, a lipofuscin fluorophore, in human retinal pigmented epithelial cells in culture. Invest Ophthalmol Vis Sci 1999; 40:2988-95.
19. Fishkin NE, Sparrow JR, Allikmets R, Nakanishi K. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc Natl Acad Sci USA 2005; 102:7091-6.
20. Jang YP, Matsuda H, Itagaki Y, Nakanishi K, Sparrow JR. Characterization of peroxy-A2E and furan-A2E photooxidation products and detection in human and mouse retinal pigment epithelial cells lipofuscin. J Biol Chem 2005; 280:39732-9.
21. Owens CWI, Belcher RV. A colorimetric micro-method for the determination of glutathione. Biochem J 1965; 94:705-11.
22. Huang YF, Chang HT. Nile red-adsorbed gold nanoparticle matrixes for determining aminothiols through surfaceassisted laser desorption/ionization mass spectrometry. Anal Chem 2006; 78:1485-93.
23. Shroyer NF, Lewis RA, Allikmets R, Singh N, Dean M, Leppert M, Lupski JR. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res 1999; 39:2537-44.
24. Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt's disease-Fundus flavimaculatus. Invest Ophthalmol Vis Sci 1995; 36:2327-31.
25. Vasireddy V, Jablonski MM, Khan NW, Wang XF, Sahu P, Sparrow JR, Ayyagari R. Elovl4 5-bp deletion knock-in mouse model for Stargardt-like macular degeneration demonstrates accumulation of ELOVL4 and lipofusin. Exp Eye Res 2009; 89:905-12.
26. Dillon J, Wang Z, Avalle LB, Gaillard ER. The photochemical oxidation of A2E results in the formation of a 5,8,5',8'-bisfuranoid oxide. Exp Eye Res 2004; 79:537-42.
27. Zhou J, Cai B, Jang YP, Pachydaki S, Schmidt AM, Sparrow JR. Mechanisms for the induction of HNE- MDA- and AGEadducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res 2005; 80:567-80.
28. Zhou J, Gao X, Cai B, Sparrow JR. Indirect antioxidant protection against photooxidative processes initiated in retinal pigment epithelial cells by a lipofuscin pigment. Rejuvenation Res 2006; 9:256-63.
29. Hipkiss AR. Aging, proteotoxicity, mitochondria, glycation, NAD+ and carnosine: possible inter-relationships and resolution of the oxygen paradox. Frontiers in Aging Neuroscience 2010; 2:10.
30. Awasthi YC, Chaudhary P, Vatsyayan R, Sharma A, Awasthi S, Sharma R. Physiological and pharmacological significance of glutathione-conjugate transport. Journal of Toxicol Environ Health. Part B 2009; 12:540-51.
31. Vander Jagt DL, Hassebrook RK, Hunsaker LA, Brown WM, Royer RE. Metabolism of the 2-oxoaldehyde methylglyoxal by aldose reductase and by glyoxalase-I: roles for glutathione in both enzymes and implications for diabetic complications. Chem Biol Interact 2001; 130-132:549-62.
32. Burstedt MSI, Ristoff E, Larsson A, Wachtmeister L. Rod-cone dystrophy with maculopathy in genetic glutathione synthetase deficiency. A morphologic and electrophysiologic study. Ophthalmology 2009; 116:324-31.
33. Milne GL, Yin H, Morrow JD. Human biochemistry of the isoprostane pathway. J Biol Chem 2008; 283:15533-7.
34. Wang W, Ballatori N. Endogenous glutathione conjugates: occurrence and biological functions. Pharmacol Rev 1998; 50:335-56.
35. Nieusma JL, Claffey DJ, Ruth JA, Ross D. Stereochemical aspects of the conjugation of epoxide metabolites of butadiene with glutathione in rat liver cytosol and freshly isolated rat Hepatocytes. Toxicol Sci 1998; 43:102-9.
36. Maggs JL, Bishop LPD, Batty KT, Dodd CC, Ilett KF, O'Neill PM, Edwards G, Park BK. Hepatocellular bioactivation and cytotoxicity of the synthetic endoperoxide antimalarial arteflene. Chem Biol Interact 2004; 147:173-84.
37. Jegerschöld C, Pawelzik S-C, Purhonen P, Bhakat P, Gheorghe KR, Gyobu N, Mitsuoka K, Morgenstern R, Jakobsson P-J, Hebert H. Structural basis of induced formation of the inflammatory mediator prostaglandin E2. Proc Natl Acad Sci USA 2008; 105:11110-5.
38. Vander Jagt DL. Methylglyoxal, diabetes mellitus and diabetic complications. Drug Metabol Drug Interact 2008; 23:93-124.